Linda F. Yrlid
BioPharmaceuticals R&D, AstraZeneca
Goeteborg, O, Sweden
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
RORγt inverse agonists demonstrating a margin between inhibition of IL-17A and thymocyte apoptosis.
Journal: PloS one
Published: January 23, 2024
PI3Kγδ inhibition suppresses key disease features in a rat model of asthma.
Journal: Respiratory research
Published: January 05, 2024
Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata.
Journal: Skin health and disease
Published: October 31, 2022
Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD.
Journal: The European respiratory journal
Published: August 28, 2020
A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
Journal: PloS one
Published: August 26, 2019
Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus.
Journal: Annals of the rheumatic diseases
Published: March 26, 2019
Polymorphisms in the multidrug-resistance 1 gene related to glucocorticoid response in rheumatoid arthritis treatment.
Journal: Rheumatology international
Published: August 11, 2016
Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.
Journal: Immunology
Published: June 26, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026